Licensed menotropin medicines have substantial randomized specialist-fertility evidence, including large IVF/ICSI trials and high-responder studies.
Regulatory status
Licensed menotropin products exist, including authorised fertility medicines. An unverified product is not automatically equivalent to a licensed medicine.
Main limitations
Use outside fertility indications or without specialist ovarian/testicular monitoring.
Safety
Major risks include ovarian hyperstimulation syndrome, multifetal gestation, thromboembolic and other reproductive-treatment complications; specialist monitoring is standard.
i
Licensed menotropin medicines have substantial randomized specialist-fertility evidence, including large IVF/ICSI trials and high-responder studies.
What the evidence actually supports
✓Move out of Needs depth after merge.
✓Adds clinically useful risk/benefit evidence.
What is not established / key limitations
×No basis to extrapolate this evidence to non-fertility or unsupervised hormone use.
×OHSS and early pregnancy loss were lower with HP-hMG in this trial.
Selected study & evidence records
Highly purified menotropin versus recombinant FSH in IVF/ICSI
Major risks include ovarian hyperstimulation syndrome, multifetal gestation, thromboembolic and other reproductive-treatment complications; specialist monitoring is standard.
Major risks include ovarian hyperstimulation syndrome, multifetal gestation, thromboembolic and other reproductive-treatment complications; specialist monitoring is standard.
Technical details
Mechanism / biologyProvides follicle-stimulating and luteinising hormone activity to stimulate gonadal function.
Route / formulation boundaryIU potency and biologic-product quality are formulation-specific.
Identity / data-quality noteUse the canonical compound identity and studied formulation when interpreting evidence.
Dosing evidence statusVerified dosing evidence added. UK licensed menotrophin dosing example. See dosing_evidence records for route, regimen, population, duration and source.
Evidence rule: WhichPeps keeps human, animal, laboratory, regulatory and product/formulation evidence distinct. Common names help people find the page; they do not change the underlying scientific identity.
